SIA METIGRINS PHARMA — Financial statements & reports

Name: Datreal.com Company Registry
Creator: Datreal.com
License: https://opendatacommons.org/licenses/by/1.0/

Income statement

Income statement
Year	Revenue	Inventory changes	Long-term investment expenses	Other operating income (by nature)	Material expenses	Labour expenses	Depreciation	Cost of goods sold	Gross profit	Selling expenses	Administrative expenses	Other operating income (by function)	Other operating expenses	Profit from equity investments	Other long-term investment income	Interest income	Investment revaluation	Interest expenses	Extraordinary income	Extraordinary expenses	Profit before taxes	Income tax provisions	Profit after taxes	Other taxes	Extraordinary dividends	Net profit
2019	143 866 €	-	-	-	-	-	-	109 596 €	34 270 €	25 945 €	6407 €	19 287 €	27 137 €	0 €	0 €	0 €	-	0 €	-	-	-5932 €	0 €	-5932 €	-	0 €	-5932 €
2018	239 930 €	-	-	-	-	-	-	227 158 €	12 772 €	15 286 €	6209 €	12 933 €	10 638 €	0 €	0 €	0 €	-	0 €	-	-	-6428 €	0 €	-6428 €	-	0 €	-6428 €

Year	Assets					Assets					Liabilities				Equity		Total liabilities & equity
Year	Cash	Securities	Receivables	Inventories	Total current assets	Investments	Intangible assets	Fixed assets	Total non-current assets	Total assets	Future housing repairs	Current liabilities	Non-current liabilities	Provisions	Capital	Total equity	Total liabilities & equity
2019	65 437 €	0 €	217 318 €	9985 €	292 740 €	0 €	31 539 €	4485 €	36 024 €	328 764 €	-	336 459 €	0 €	0 €	-7695 €	328 764 €	328 764 €
2018	86 548 €	0 €	158 747 €	15 390 €	260 685 €	0 €	0 €	0 €	0 €	260 685 €	-	262 448 €	0 €	0 €	-1763 €	260 685 €	260 685 €

Year	Operating cash flow	Investing cash flow	Financing cash flow	Net cash change
2019	Not available
2018	Not available

Year	Total taxes	Change	Income tax	Social tax	Employees
2024	1680 €	67.8%	0 €	1680 €	40%
2023	5210 €	65.7%	1270 €	3920 €	4-20%
2022	15 170 €	-	5290 €	10 180 €	5